Pembrolizumab vs Valproic Acid
Pembrolizumab vs Valproic Acid: Overview
This comparison examines the pharmacological differences between Pembrolizumab and Valproic Acid.
Mechanism of Action
Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.
Valproic Acid: Enhances GABA transmission and blocks sodium/calcium channels.
Pharmacokinetics
Half-life: Pembrolizumab — 26 days; Valproic Acid — 9-16 hours.
Chemical Properties
Molecular Formula: Valproic Acid — C8H16O2.
Molecular Weight: Valproic Acid — 144.2110 g/mol.
Type: Pembrolizumab — Antibody; Valproic Acid — Small molecule.